Neurocrine Biosciences Operating Expenses 2010-2024 | NBIX
Neurocrine Biosciences operating expenses for the twelve months ending September 30, 2024 were $1.664B, a 5.32% increase year-over-year.
- Neurocrine Biosciences annual operating expenses for 2023 were $1.636B, a 31.98% increase from 2022.
- Neurocrine Biosciences annual operating expenses for 2022 were $1.24B, a 20.24% increase from 2021.
- Neurocrine Biosciences annual operating expenses for 2021 were $1.031B, a 16.77% increase from 2020.